Mee Kyung Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mee Kyung Ko has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jongyoun Yi
Department of Laboratory Medicine, Pusan National University School of Medicine, Busan 49241, Republic of Korea
8 shared publications - Kye-Hyung Kim
Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea
8 shared publications - Ahreum Kim
Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea
2 shared publications - Changhoon Kim
Department of Preventive Medicine, School of Medicine, Pusan National University
2 shared publications - Hyung-Hoi Kim
Department of Medicine, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea
2 shared publications - Hyunjin Son
Department of Preventive Medicine, Dong-A University School of Medicine, Busan 49201, Republic of Korea
2 shared publications
Latest Publications
- Open Access
Seroprevalence and Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome in Patients with Chronic Diseases in Korea
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with a high mortality rate. While research has focused on high-risk rural populations and healthy individuals in endemic regions, such as Jeju Island, data on patients with underlying chronic diseases remain limited. This study aimed to evaluate the seroprevalence of SFTS virus (SFTSV) in patients with various chronic diseases across the Republic of Korea. Serum samples (n = 2948) collected from 10 regional biobanks between 2009 and 2019 were analyzed using a double-antigen sandwich enzyme-linked immunosorbent assay. The overall seroprevalence was 1.22% (36/2948). Seropositivity was significantly higher in males (1.73%) than in females (0.73%, p = 0.013) and increased with age (p = 0.001), peaking at 2.73% in individuals aged 70–79. Geographically, the highest rates were in Gyeongbuk (3.03%), Jeonnam (2.40%), and Gangwon (1.83%). Multivariable logistic regression showed older age (adjusted odds ratio 1.47 per 10-year increase, 95% confidence interval: 1.12–1.97) as the strongest independent predictor of seropositivity. Patients with hepatobiliary/pancreatic cancer (3.16%) and prostate cancer (2.50%) exhibited higher seroprevalence than those in other disease groups. SFTSV exposure is non-negligible among those with chronic diseases, particularly older males in rural provinces. Public health strategies should specifically address these vulnerable populations.
Open AccessSeroprevalence and Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome in Patients with Chronic Diseases in Korea
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with a high mortality rate. While research has focused on high-risk rural populations and healthy individuals in endemic regions, such as Jeju Island, data on patients with underlying chronic diseases remain limited. This study aimed to evaluate the seroprevalence of SFTS virus (SFTSV) in patients with various chronic diseases across the Republic of Korea. Serum samples (n = 2948) collected from 10 regional biobanks between 2009 and 2019 were analyzed using a double-antigen sandwich enzyme-linked immunosorbent assay. The overall seroprevalence was 1.22% (36/2948). Seropositivity was significantly higher in males (1.73%) than in females (0.73%, p = 0.013) and increased with age (p = 0.001), peaking at 2.73% in individuals aged 70–79. Geographically, the highest rates were in Gyeongbuk (3.03%), Jeonnam (2.40%), and Gangwon (1.83%). Multivariable logistic regression showed older age (adjusted odds ratio 1.47 per 10-year increase, 95% confidence interval: 1.12–1.97) as the strongest independent predictor of seropositivity. Patients with hepatobiliary/pancreatic cancer (3.16%) and prostate cancer (2.50%) exhibited higher seroprevalence than those in other disease groups. SFTSV exposure is non-negligible among those with chronic diseases, particularly older males in rural provinces. Public health strategies should specifically address these vulnerable populations.
- Open Access
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46826
Seroprevalence survey and estimated infection fatality rate of SARS-CoV-2 in Daegu, Republic of Korea – Lessons learned for preparing for new emerging viral disease epidemics: A cross-sectional study
Daegu in the Republic of Korea experienced the 1st major community outbreak of coronavirus disease 2019 (COVID-19) outside China in February 2020. The infection fatality rate (IFR) and herd immunity level of COVID-19 in the early stages of the pandemic have not been thoroughly investigated in Korea. The aim of this study was to assess the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and IFR prior to the introduction of COVID-19 vaccines. We conducted a seroprevalence survey in Daegu, using a convenience sample of residual serum specimens from 1500 individuals during August and September 2020. The serum specimens were provided by a commercial referral laboratory. The primary outcome measures were the seroprevalence of SARS-CoV-2 binding antibodies and neutralizing antibodies. The calculated case fatality rate (CFR) and IFR were secondary outcome measures. Of 1500 serum specimens tested for SARS-CoV-2 binding and neutralizing antibodies, the seroprevalences were 0.8% for binding antibodies and 0.3% for neutralizing antibodies. The estimated IFR (1.00%) and CFR (2.71%) for COVID-19 were significantly higher than the CFR for influenza in the Republic of Korea (0.03–0.18%). In September 2020, most Daegu residents had not developed antibodies against SARS-CoV-2, despite the major outbreak earlier that year. In the early stages of a major viral epidemic such as COVID-19, when herd immunity has not been established and vaccines and treatments are not yet available, rigorous contact tracing and isolation of those who are infected are crucial for containing the spread.
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e46826
Open AccessSeroprevalence survey and estimated infection fatality rate of SARS-CoV-2 in Daegu, Republic of Korea – Lessons learned for preparing for new emerging viral disease epidemics: A cross-sectional study
Daegu in the Republic of Korea experienced the 1st major community outbreak of coronavirus disease 2019 (COVID-19) outside China in February 2020. The infection fatality rate (IFR) and herd immunity level of COVID-19 in the early stages of the pandemic have not been thoroughly investigated in Korea. The aim of this study was to assess the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and IFR prior to the introduction of COVID-19 vaccines. We conducted a seroprevalence survey in Daegu, using a convenience sample of residual serum specimens from 1500 individuals during August and September 2020. The serum specimens were provided by a commercial referral laboratory. The primary outcome measures were the seroprevalence of SARS-CoV-2 binding antibodies and neutralizing antibodies. The calculated case fatality rate (CFR) and IFR were secondary outcome measures. Of 1500 serum specimens tested for SARS-CoV-2 binding and neutralizing antibodies, the seroprevalences were 0.8% for binding antibodies and 0.3% for neutralizing antibodies. The estimated IFR (1.00%) and CFR (2.71%) for COVID-19 were significantly higher than the CFR for influenza in the Republic of Korea (0.03–0.18%). In September 2020, most Daegu residents had not developed antibodies against SARS-CoV-2, despite the major outbreak earlier that year. In the early stages of a major viral epidemic such as COVID-19, when herd immunity has not been established and vaccines and treatments are not yet available, rigorous contact tracing and isolation of those who are infected are crucial for containing the spread.
- Open Access
Seroprevalence and Epidemiological Insights into Severe Fever with Thrombocytopenia Syndrome on Jeju Island, Republic of Korea
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease caused by the SFTS virus, posing significant public health challenges in East Asia. This study aimed to evaluate the seroprevalence of SFTS on Jeju Island, Korea, and to identify the demographic and geographic factors influencing exposure to the virus. A total of 1001 serum samples collected from healthy individuals between 2009 and 2016 were analyzed using a double-antigen enzyme-linked immunosorbent assay. The overall seroprevalence was 1.7%, with slightly higher rates observed in females (2.06%) than in males (1.29%); however, this difference was not statistically significant. Seroprevalence increased with age, peaking at 2.50% in individuals over aged 60 and over. Regional analysis revealed elevated seroprevalence in the eastern coastal areas (4.41%), which was attributed to population density and environmental factors favoring human–tick interactions. These findings suggest that population distribution and land use patterns, rather than altitude alone, significantly affect the exposure of SFTS on Jeju Island. Targeted tick control strategies and public health interventions that focus on high-risk regions and demographics could mitigate SFTS transmission. This study provides valuable insights into the epidemiological characteristics of SFTS and emphasizes the importance of tailored preventive measures in endemic regions.
Open AccessSeroprevalence and Epidemiological Insights into Severe Fever with Thrombocytopenia Syndrome on Jeju Island, Republic of Korea
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease caused by the SFTS virus, posing significant public health challenges in East Asia. This study aimed to evaluate the seroprevalence of SFTS on Jeju Island, Korea, and to identify the demographic and geographic factors influencing exposure to the virus. A total of 1001 serum samples collected from healthy individuals between 2009 and 2016 were analyzed using a double-antigen enzyme-linked immunosorbent assay. The overall seroprevalence was 1.7%, with slightly higher rates observed in females (2.06%) than in males (1.29%); however, this difference was not statistically significant. Seroprevalence increased with age, peaking at 2.50% in individuals over aged 60 and over. Regional analysis revealed elevated seroprevalence in the eastern coastal areas (4.41%), which was attributed to population density and environmental factors favoring human–tick interactions. These findings suggest that population distribution and land use patterns, rather than altitude alone, significantly affect the exposure of SFTS on Jeju Island. Targeted tick control strategies and public health interventions that focus on high-risk regions and demographics could mitigate SFTS transmission. This study provides valuable insights into the epidemiological characteristics of SFTS and emphasizes the importance of tailored preventive measures in endemic regions.
- Open Access
- 4 October 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (40) , e39995
Diagnostic accuracy of rapid antigen tests for detection of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2: Direct evidence from prospective clinical settings
Despite widespread application during the coronavirus disease-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection using patient-performed rapid antigen tests (RATs) is limited, especially regarding the Delta and Omicron variants. Therefore, in this study, we evaluated the performance of RATs in identifying Delta and Omicron infections in self-test settings. In this multicenter clinical performance study conducted in Korea between November 2021 and February 2022, we included participants without prior diagnostic device experience. Using 2 RAT types, we compared the results with real-time reverse transcriptase-polymerase chain reaction testing, focusing on clinical sensitivity and specificity. Reverse transcriptase-polymerase chain reaction helped confirm 77 SARS-CoV-2 infections among 280 participants. RATs exhibited high positive agreement for Omicron detection but lower rates for Delta, especially among partially vaccinated individuals. This study provides direct evidence that RATs, originally developed for ancestral strains of SARS-CoV-2, effectively detect major variants such as Delta and Omicron in real patient/clinical settings. By confirming variant presence through sequencing, our research offers significant and novel insights into the performance of RATs, particularly in the context of breakthrough infections postvaccination, with precise data on vaccination status and timing obtained from government records.
- 4 October 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (40) , e39995
Open AccessDiagnostic accuracy of rapid antigen tests for detection of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2: Direct evidence from prospective clinical settings
Despite widespread application during the coronavirus disease-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection using patient-performed rapid antigen tests (RATs) is limited, especially regarding the Delta and Omicron variants. Therefore, in this study, we evaluated the performance of RATs in identifying Delta and Omicron infections in self-test settings. In this multicenter clinical performance study conducted in Korea between November 2021 and February 2022, we included participants without prior diagnostic device experience. Using 2 RAT types, we compared the results with real-time reverse transcriptase-polymerase chain reaction testing, focusing on clinical sensitivity and specificity. Reverse transcriptase-polymerase chain reaction helped confirm 77 SARS-CoV-2 infections among 280 participants. RATs exhibited high positive agreement for Omicron detection but lower rates for Delta, especially among partially vaccinated individuals. This study provides direct evidence that RATs, originally developed for ancestral strains of SARS-CoV-2, effectively detect major variants such as Delta and Omicron in real patient/clinical settings. By confirming variant presence through sequencing, our research offers significant and novel insights into the performance of RATs, particularly in the context of breakthrough infections postvaccination, with precise data on vaccination status and timing obtained from government records.
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Korean Medical Science
- Vol. 34 (18) , e140
Prevalence and Risk Factors of Carbapenem-resistantEnterobacteriaceaeAcquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study
Kang JS, et al. J Korean Med Sci. 2019 Apr;34(18):e140. https://doi.org/10.3346/jkms.2019.34.e140
- 1 January 2019
- Published by XMLink in Journal of Korean Medical Science
- Vol. 34 (18) , e140
Open AccessPrevalence and Risk Factors of Carbapenem-resistantEnterobacteriaceaeAcquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study
Kang JS, et al. J Korean Med Sci. 2019 Apr;34(18):e140. https://doi.org/10.3346/jkms.2019.34.e140
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (50) , e319
Severe Fever with Thrombocytopenia Syndrome Patients with Hemophagocytic Lymphohistiocytosis Retrospectively Identified in Korea, 2008–2013
Kim KH, et al. J Korean Med Sci. 2018 Oct;33(50):e319. https://doi.org/10.3346/jkms.2018.33.e319
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (50) , e319
Open AccessSevere Fever with Thrombocytopenia Syndrome Patients with Hemophagocytic Lymphohistiocytosis Retrospectively Identified in Korea, 2008–2013
Kim KH, et al. J Korean Med Sci. 2018 Oct;33(50):e319. https://doi.org/10.3346/jkms.2018.33.e319
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (30) , e225
Erratum: Correction of Author Information and Funding Source: Seroprevalence of Severe Fever with Thrombocytopenia Syndrome in Southeastern Korea, 2015
Kim KH, et al. J Korean Med Sci. 2018 May;33(30):e225. https://doi.org/10.3346/jkms.2018.33.e225
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (30) , e225
Open AccessErratum: Correction of Author Information and Funding Source: Seroprevalence of Severe Fever with Thrombocytopenia Syndrome in Southeastern Korea, 2015
Kim KH, et al. J Korean Med Sci. 2018 May;33(30):e225. https://doi.org/10.3346/jkms.2018.33.e225
- Open Access
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (1) , 29-32
Seroprevalence of Severe Fever with Thrombocytopenia Syndrome in Southeastern Korea, 2015
Kim KH, et al. J Korean Med Sci. 2017 Jan;32(1):29-32. https://doi.org/10.3346/jkms.2017.32.1.29
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (1) , 29-32
Open AccessSeroprevalence of Severe Fever with Thrombocytopenia Syndrome in Southeastern Korea, 2015
Kim KH, et al. J Korean Med Sci. 2017 Jan;32(1):29-32. https://doi.org/10.3346/jkms.2017.32.1.29